1. Home
  2. MTEX vs AYTU Comparison

MTEX vs AYTU Comparison

Compare MTEX & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEX
  • AYTU
  • Stock Information
  • Founded
  • MTEX 1993
  • AYTU N/A
  • Country
  • MTEX United States
  • AYTU United States
  • Employees
  • MTEX N/A
  • AYTU N/A
  • Industry
  • MTEX Medicinal Chemicals and Botanical Products
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTEX Health Care
  • AYTU Health Care
  • Exchange
  • MTEX Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • MTEX 18.2M
  • AYTU 20.5M
  • IPO Year
  • MTEX 1999
  • AYTU N/A
  • Fundamental
  • Price
  • MTEX $9.84
  • AYTU $1.98
  • Analyst Decision
  • MTEX
  • AYTU Strong Buy
  • Analyst Count
  • MTEX 0
  • AYTU 3
  • Target Price
  • MTEX N/A
  • AYTU $9.17
  • AVG Volume (30 Days)
  • MTEX 24.2K
  • AYTU 64.1K
  • Earning Date
  • MTEX 11-12-2025
  • AYTU 11-13-2025
  • Dividend Yield
  • MTEX N/A
  • AYTU N/A
  • EPS Growth
  • MTEX N/A
  • AYTU N/A
  • EPS
  • MTEX N/A
  • AYTU N/A
  • Revenue
  • MTEX $110,411,000.00
  • AYTU $63,696,000.00
  • Revenue This Year
  • MTEX N/A
  • AYTU N/A
  • Revenue Next Year
  • MTEX N/A
  • AYTU $29.12
  • P/E Ratio
  • MTEX N/A
  • AYTU N/A
  • Revenue Growth
  • MTEX N/A
  • AYTU N/A
  • 52 Week Low
  • MTEX $7.50
  • AYTU $0.95
  • 52 Week High
  • MTEX $16.49
  • AYTU $2.82
  • Technical
  • Relative Strength Index (RSI)
  • MTEX 57.80
  • AYTU 47.97
  • Support Level
  • MTEX $9.34
  • AYTU $1.91
  • Resistance Level
  • MTEX $9.86
  • AYTU $2.10
  • Average True Range (ATR)
  • MTEX 0.39
  • AYTU 0.16
  • MACD
  • MTEX 0.03
  • AYTU -0.00
  • Stochastic Oscillator
  • MTEX 95.21
  • AYTU 58.00

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: